Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

NCT00286455 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

329

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Alogliptin
DRUG: Alogliptin
DRUG: Placebo

Sponsor

Takeda